2018 Q1 Form 10-Q Financial Statement
#000114420418036698 Filed on June 29, 2018
Income Statement
| Concept | 2018 Q1 | 2017 Q1 |
|---|---|---|
| Revenue | $198.0K | $2.717M |
| YoY Change | -92.71% | 1112.95% |
| Cost Of Revenue | $0.00 | $130.0K |
| YoY Change | -100.0% | 30.0% |
| Gross Profit | $200.0K | $2.590M |
| YoY Change | -92.28% | 2058.33% |
| Gross Profit Margin | 101.01% | 95.33% |
| Selling, General & Admin | $943.0K | $1.296M |
| YoY Change | -27.24% | -42.3% |
| % of Gross Profit | 471.5% | 50.04% |
| Research & Development | $650.0K | $711.0K |
| YoY Change | -8.58% | -29.88% |
| % of Gross Profit | 325.0% | 27.45% |
| Depreciation & Amortization | $70.00K | $80.00K |
| YoY Change | -12.5% | 135.29% |
| % of Gross Profit | 35.0% | 3.09% |
| Operating Expenses | $1.593M | $2.007M |
| YoY Change | -20.63% | -38.44% |
| Operating Profit | -$1.395M | $582.0K |
| YoY Change | -339.69% | -118.55% |
| Interest Expense | $99.00K | $177.0K |
| YoY Change | -44.07% | -28.92% |
| % of Operating Profit | 30.41% | |
| Other Income/Expense, Net | -$177.0K | |
| YoY Change | -28.05% | |
| Pretax Income | -$1.494M | $405.0K |
| YoY Change | -468.89% | -111.97% |
| Income Tax | $0.00 | $0.00 |
| % Of Pretax Income | 0.0% | |
| Net Earnings | -$1.494M | $405.0K |
| YoY Change | -468.89% | -111.97% |
| Net Earnings / Revenue | -754.55% | 14.91% |
| Basic Earnings Per Share | -$0.07 | $0.03 |
| Diluted Earnings Per Share | -$0.07 | $0.03 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 21.03M shares | 11.91M shares |
| Diluted Shares Outstanding | 21.03M shares | 12.08M shares |
Balance Sheet
| Concept | 2018 Q1 | 2017 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $770.0K | $3.840M |
| YoY Change | -79.95% | -65.0% |
| Cash & Equivalents | $774.0K | $3.843M |
| Short-Term Investments | ||
| Other Short-Term Assets | $120.0K | $2.800M |
| YoY Change | -95.71% | 833.33% |
| Inventory | $0.00 | |
| Prepaid Expenses | ||
| Receivables | $40.00K | |
| Other Receivables | $50.00K | |
| Total Short-Term Assets | $1.082M | $6.738M |
| YoY Change | -83.94% | -42.06% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $660.0K | $739.0K |
| YoY Change | -10.69% | -28.25% |
| Goodwill | ||
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | ||
| YoY Change | ||
| Total Long-Term Assets | $1.968M | $2.118M |
| YoY Change | -7.08% | -24.09% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $1.082M | $6.738M |
| Total Long-Term Assets | $1.968M | $2.118M |
| Total Assets | $3.050M | $8.856M |
| YoY Change | -65.56% | -38.59% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $416.0K | $209.0K |
| YoY Change | 99.04% | -45.0% |
| Accrued Expenses | $817.0K | $1.040M |
| YoY Change | -21.44% | -14.05% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $2.228M | $2.798M |
| YoY Change | -20.37% | 8.66% |
| Total Short-Term Liabilities | $4.470M | $4.403M |
| YoY Change | 1.52% | -0.61% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $0.00 | $2.142M |
| YoY Change | -100.0% | -55.47% |
| Other Long-Term Liabilities | $600.0K | |
| YoY Change | 39.53% | |
| Total Long-Term Liabilities | $0.00 | $2.142M |
| YoY Change | -100.0% | -59.12% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $4.470M | $4.403M |
| Total Long-Term Liabilities | $0.00 | $2.142M |
| Total Liabilities | $4.473M | $7.143M |
| YoY Change | -37.38% | -26.13% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$381.9M | -$374.3M |
| YoY Change | 2.03% | |
| Common Stock | $380.4M | $376.0M |
| YoY Change | 1.18% | |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | -$1.430M | $1.713M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $3.050M | $8.856M |
| YoY Change | -65.56% | -38.59% |
Cashflow Statement
| Concept | 2018 Q1 | 2017 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$1.494M | $405.0K |
| YoY Change | -468.89% | -111.97% |
| Depreciation, Depletion And Amortization | $70.00K | $80.00K |
| YoY Change | -12.5% | 135.29% |
| Cash From Operating Activities | -$965.0K | $1.298M |
| YoY Change | -174.35% | -167.6% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $0.00 | |
| YoY Change | -100.0% | |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | $0.00 | $310.0K |
| YoY Change | -100.0% | -90.25% |
| Cash From Investing Activities | $0.00 | $309.0K |
| YoY Change | -100.0% | -90.13% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | -$481.0K | -$445.0K |
| YoY Change | 8.09% | 8.54% |
| NET CHANGE | ||
| Cash From Operating Activities | -$965.0K | $1.298M |
| Cash From Investing Activities | $0.00 | $309.0K |
| Cash From Financing Activities | -$481.0K | -$445.0K |
| Net Change In Cash | -$1.446M | $1.162M |
| YoY Change | -224.44% | 45.25% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$965.0K | $1.298M |
| Capital Expenditures | $0.00 | |
| Free Cash Flow | $1.298M | |
| YoY Change | -165.92% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2017 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
5200000 | USD |
| CY2018Q1 | us-gaap |
Assets Current
AssetsCurrent
|
1082000 | USD |
| CY2017Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
275000 | USD |
| CY2018Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
416000 | USD |
| CY2018Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
817000 | USD |
| CY2018Q1 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
13000 | USD |
| CY2018Q1 | acur |
Sales Returns Liability Current
SalesReturnsLiabilityCurrent
|
254000 | USD |
| CY2017Q4 | acur |
Sales Returns Liability Current
SalesReturnsLiabilityCurrent
|
254000 | USD |
| CY2018Q1 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
2228000 | USD |
| CY2017Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
2694000 | USD |
| CY2018Q1 | us-gaap |
Liabilities
Liabilities
|
4473000 | USD |
| CY2017Q4 | us-gaap |
Liabilities
Liabilities
|
4631000 | USD |
| CY2018Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
116000 | USD |
| CY2018Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
210000 | USD |
| CY2017Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
208000 | USD |
| CY2018Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
380239000 | USD |
| CY2017Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
380145000 | USD |
| CY2018Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-381874000 | USD |
| CY2017Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-380380000 | USD |
| CY2017Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
405000 | USD |
| CY2018Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.07 | |
| CY2017Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.03 | |
| CY2018Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.07 | |
| CY2017Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.03 | |
| CY2018Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2017Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2018Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
21034000 | shares |
| CY2017Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
11907000 | shares |
| CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-27000 | USD |
| CY2017Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
4604000 | USD |
| CY2017Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2220000 | USD |
| CY2018Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
774000 | USD |
| CY2018Q1 | acur |
Royalty Receivable
RoyaltyReceivable
|
192000 | USD |
| CY2018Q1 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
745000 | USD |
| CY2018Q1 | us-gaap |
Royalty Revenue
RoyaltyRevenue
|
198000 | USD |
| CY2018Q1 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
0 | USD |
| CY2018Q1 | us-gaap |
License And Services Revenue
LicenseAndServicesRevenue
|
0 | USD |
| CY2018Q1 | us-gaap |
Revenues
Revenues
|
198000 | USD |
| CY2018Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
650000 | USD |
| CY2018Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
943000 | USD |
| CY2018Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1395000 | USD |
| CY2018Q1 | us-gaap |
Interest Expense
InterestExpense
|
99000 | USD |
| CY2017Q1 | us-gaap |
Interest Expense
InterestExpense
|
177000 | USD |
| CY2018Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-1494000 | USD |
| CY2017Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
405000 | USD |
| CY2018Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1494000 | USD |
| CY2018Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
21034000 | shares |
| CY2017Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
12083000 | shares |
| CY2018Q1 | us-gaap |
Other Sales Revenue Net
OtherSalesRevenueNet
|
0 | USD |
| CY2017Q1 | us-gaap |
Other Sales Revenue Net
OtherSalesRevenueNet
|
36000 | USD |
| CY2018Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
1593000 | USD |
| CY2017Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
2135000 | USD |
| CY2018Q1 | acur |
Cost Of Sales Excluding Inventory Write Down
CostOfSalesExcludingInventoryWriteDown
|
0 | USD |
| CY2017Q1 | acur |
Cost Of Sales Excluding Inventory Write Down
CostOfSalesExcludingInventoryWriteDown
|
128000 | USD |
| CY2018Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
34000 | USD |
| CY2018Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
20000 | USD |
| CY2018Q1 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
17000 | USD |
| CY2017Q1 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
30000 | USD |
| CY2017Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
52000 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-103000 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
33000 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
132000 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
337000 | USD |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-965000 | USD |
| CY2017Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
1298000 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
74000 | USD |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-481000 | USD |
| CY2017Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-445000 | USD |
| CY2018Q1 | acur |
Provision For Sales Returns
ProvisionForSalesReturns
|
0 | USD |
| CY2018Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
2000 | USD |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | USD |
| CY2017Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
309000 | USD |
| CY2018Q1 | us-gaap |
Repayments Of Debt
RepaymentsOfDebt
|
483000 | USD |
| CY2018Q1 | acur |
Increase Decrease In Collaboration Revenue Receivable
IncreaseDecreaseInCollaborationRevenueReceivable
|
0 | USD |
| CY2017Q1 | acur |
Increase Decrease In Collaboration Revenue Receivable
IncreaseDecreaseInCollaborationRevenueReceivable
|
-43000 | USD |
| CY2018Q1 | acur |
Increase Decrease In Sales Return Liability
IncreaseDecreaseInSalesReturnLiability
|
0 | USD |
| CY2017Q1 | acur |
Increase Decrease In Sales Return Liability
IncreaseDecreaseInSalesReturnLiability
|
51000 | USD |
| CY2018Q1 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
0 | USD |
| CY2017Q1 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
103000 | USD |
| CY2018Q1 | acur |
Proceeds From Sale Of Inventory
ProceedsFromSaleOfInventory
|
0 | USD |
| CY2017Q1 | acur |
Proceeds From Sale Of Inventory
ProceedsFromSaleOfInventory
|
206000 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
0 | USD |
| CY2018Q1 | us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
4000 | USD |
| CY2018Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-1446000 | USD |
| CY2017Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
1162000 | USD |
| CY2016Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
5181000 | USD |
| CY2017Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
6343000 | USD |
| CY2018Q1 | acur |
Increase Decrease In Royalty Receivable
IncreaseDecreaseInRoyaltyReceivable
|
121000 | USD |
| CY2017Q1 | acur |
Increase Decrease In Royalty Receivable
IncreaseDecreaseInRoyaltyReceivable
|
2000 | USD |
| CY2017Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
3843000 | USD |
| CY2018Q1 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
0 | USD |
| CY2017Q1 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
2500000 | USD |
| CY2018Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1853000 | USD |
| CY2017Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1833000 | USD |
| CY2018Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
2512000 | USD |
| CY2017Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
2512000 | USD |
| CY2018Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
82000 | USD |
| CY2017Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
70000 | USD |
| CY2018Q1 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
190000 | USD |
| CY2017Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
149000 | USD |
| CY2018Q1 | acur |
Other Accrued Taxes Current
OtherAccruedTaxesCurrent
|
14000 | USD |
| CY2017Q4 | acur |
Other Accrued Taxes Current
OtherAccruedTaxesCurrent
|
14000 | USD |
| CY2018Q1 | us-gaap |
Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
|
18000 | USD |
| CY2017Q4 | us-gaap |
Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
|
16000 | USD |
| CY2018Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
35000 | USD |
| CY2017Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
36000 | USD |
| CY2017Q4 | acur |
Accrued Other Professional Fees Current
AccruedOtherProfessionalFeesCurrent
|
326000 | USD |
| CY2018Q1 | acur |
Accrued Other Professional Fees Current
AccruedOtherProfessionalFeesCurrent
|
96000 | USD |
| CY2018Q1 | acur |
Accrued Cost Sharing Expenses
AccruedCostSharingExpenses
|
382000 | USD |
| CY2017Q4 | acur |
Accrued Cost Sharing Expenses
AccruedCostSharingExpenses
|
328000 | USD |
| CY2013Q4 | acur |
Debt Default Long Term Debt Percentage
DebtDefaultLongTermDebtPercentage
|
0.1335 | pure |
| CY2018Q1 | us-gaap |
Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
|
260000 | USD |
| CY2015Q1 | acur |
Debt Instrument Cash Maintenance
DebtInstrumentCashMaintenance
|
2500000 | USD |
| CY2016Q4 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
6000000 | USD |
| CY2017Q3 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
4000000 | USD |
| CY2018Q1 | us-gaap |
Debt Instrument Fee Amount
DebtInstrumentFeeAmount
|
50000 | USD |
| CY2018Q1 | acur |
Debt Consulting Placement Fee
DebtConsultingPlacementFee
|
100000 | USD |
| CY2018Q1 | us-gaap |
Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
|
0.1016 | pure |
| CY2018Q1 | us-gaap |
Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
|
483000 | USD |
| CY2018Q1 | acur |
Debt Instrument Classification Amount
DebtInstrumentClassificationAmount
|
0 | USD |
| CY2017Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
2740000 | USD |
| CY2018Q1 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
2257000 | USD |
| CY2018Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
12000 | USD |
| CY2017Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
32000 | USD |
| CY2018Q1 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
20000 | USD |
| CY2018Q1 | acur |
Classification Of Debt Discount Premium
ClassificationOfDebtDiscountPremium
|
0 | USD |
| CY2017Q4 | acur |
Debt Instrument Issuance Costs
DebtInstrumentIssuanceCosts
|
14000 | USD |
| CY2018Q1 | acur |
Amortization Expense Of Debt Instrument Issuance Costs
AmortizationExpenseOfDebtInstrumentIssuanceCosts
|
5000 | USD |
| CY2018Q1 | acur |
Debt Instrument Issuance Costs
DebtInstrumentIssuanceCosts
|
9000 | USD |
| CY2018Q1 | us-gaap |
Long Term Debt
LongTermDebt
|
2228000 | USD |
| CY2018Q1 | acur |
Classification Of Deferred Debt Issuance Costs
ClassificationOfDeferredDebtIssuanceCosts
|
0 | USD |
| CY2018Q1 | acur |
Interest Expense Debt Discount
InterestExpenseDebtDiscount
|
12000 | USD |
| CY2017Q1 | acur |
Interest Expense Debt Discount
InterestExpenseDebtDiscount
|
20000 | USD |
| CY2018Q1 | us-gaap |
Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
|
5000 | USD |
| CY2017Q1 | us-gaap |
Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
|
10000 | USD |
| CY2018Q1 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
99000 | USD |
| CY2017Q1 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
178000 | USD |
| CY2017Q3 | acur |
Number Of Common Stock Need To Hold To Designate As Director
NumberOfCommonStockNeedToHoldToDesignateAsDirector
|
600000 | shares |
| CY2013Q4 | us-gaap |
Secured Debt
SecuredDebt
|
10000000 | USD |
| CY2018Q1 | acur |
Share Based Compensation Expense Recognized In Operations
ShareBasedCompensationExpenseRecognizedInOperations
|
76000 | USD |
| CY2017Q1 | acur |
Share Based Compensation Expense Recognized In Operations
ShareBasedCompensationExpenseRecognizedInOperations
|
117000 | USD |
| CY2018Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
67000 | USD |
| CY2018Q1 | acur |
Accrued Cost Sharing Expenses Clinical Studies
AccruedCostSharingExpensesClinicalStudies
|
382000 | USD |
| CY2018Q1 | us-gaap |
Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
|
135000 | USD |
| CY2017Q4 | us-gaap |
Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
|
135000 | USD |
| CY2018Q1 | us-gaap |
Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
|
828000 | USD |
| CY2017Q4 | us-gaap |
Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
|
776000 | USD |
| CY2018Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2018Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
| CY2017Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
| CY2018Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
21034000 | shares |
| CY2017Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
20796000 | shares |
| CY2017Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
20796000 | shares |
| CY2018Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
21034000 | shares |
| CY2018Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
62000 | USD |
| CY2018Q1 | acur |
Cash Cash Equivalent And Marketable Securities
CashCashEquivalentAndMarketableSecurities
|
800000 | USD |
| CY2018Q1 | acur |
Working Capital
WorkingCapital
|
3400000 | USD |
| CY2018Q1 | acur |
Agreement Termination Notice Description
AgreementTerminationNoticeDescription
|
Egalet may terminate the Egalet Agreement for convenience on 120 days prior written notice, which termination may not occur prior to the second anniversary of Egalets launch of Oxaydo. Termination does not affect a partys rights accrued prior thereto, but there are no stated payments in connection with termination other than payments of obligations previously accrued. For all terminations (but not expiration), the Egalet Agreement provides for the transition of development and marketing of Oxaydo from Egalet to us, including the conveyance by Egalet to us of the trademarks and all regulatory filings and approvals relating to Oxaydo, and for Egalets supply of Oxaydo for a transition period. | |
| CY2017Q1 | acur |
License Agreement Option Products Description
LicenseAgreementOptionProductsDescription
|
In addition, MainPointe has the option to add to the MainPointe Agreement certain additional products, or Option Products, containing PSE and utilizing the Impede technology for a fee of $500 thousand per product (for all product strengths). Such Option Products include the product candidate Loratadine with pseudoephedrine. If the territory has been expanded prior to the exercise of a product option, the option fee will be increased to $750 thousand per product. If the territory is expanded after the payment of the $500 thousand product option fee, a one-time $250 thousand fee will be due for each product. If a third party is interested in developing or licensing rights to an Option Product, MainPointe must exercise its option for that product or its option rights for such product will terminate. | |
| CY2018Q1 | us-gaap |
State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
|
1000000 | USD |
| CY2018Q1 | acur |
Operating Loss Carryforwards Expiration Term
OperatingLossCarryforwardsExpirationTerm
|
P20Y | |
| CY2018Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
4000000 | USD |
| CY2018Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3725000 | shares |
| CY2018Q1 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
21033000 | shares |
| CY2017Q1 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
11881000 | shares |
| CY2018Q1 | us-gaap |
Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
|
1000 | shares |
| CY2017Q1 | us-gaap |
Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
|
26000 | shares |
| CY2017Q1 | acur |
Incremental Common Shares Attributable To Conversion Of Common Stock
IncrementalCommonSharesAttributableToConversionOfCommonStock
|
11881000 | shares |
| CY2018Q1 | acur |
Incremental Common Shares Attributable To Conversion Of Common Stock
IncrementalCommonSharesAttributableToConversionOfCommonStock
|
21033000 | shares |
| CY2017Q1 | acur |
Incremental Common Shares Attributable To Restricted Stock
IncrementalCommonSharesAttributableToRestrictedStock
|
202000 | shares |
| CY2018Q1 | acur |
Incremental Common Shares Attributable To Restricted Stock
IncrementalCommonSharesAttributableToRestrictedStock
|
1000 | shares |
| CY2018Q1 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.35 | pure |
| CY2018Q1 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
169000000 | USD |
| CY2018Q1 | acur |
Operating Loss Carry Forwards Expiration Year
OperatingLossCarryForwardsExpirationYear
|
2037 | |
| CY2018Q1 | us-gaap |
Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
|
150000 | USD |
| CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
0 | USD |
| CY2017Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
0 | USD |
| CY2013Q4 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
10000000 | USD |
| CY2017Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2018Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2018Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
62000 | USD |
| CY2017Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
117000 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-17000 | USD |
| CY2018Q2 | acur |
Cash Cash Equivalents And Refundable Deposits
CashCashEquivalentsAndRefundableDeposits
|
700000 | USD |
| CY2018Q1 | acur |
Contract Balance And Performance Obligationsdescription
ContractBalanceAndPerformanceObligationsdescription
|
The Companys reported contract assets and contract liability balances under the license and collaboration agreements at either March 31, 2018 or December 31, 2017 was $0.00. | |
| CY2018Q1 | acur |
Interest Expense Term Loan
InterestExpenseTermLoan
|
82000 | USD |
| CY2017Q1 | acur |
Interest Expense Term Loan
InterestExpenseTermLoan
|
148000 | USD |
| CY2018Q1 | us-gaap |
Investment Income Nonoperating
InvestmentIncomeNonoperating
|
0 | USD |
| CY2017Q1 | us-gaap |
Investment Income Nonoperating
InvestmentIncomeNonoperating
|
1000 | USD |
